Plus Disease in Retinopathy of Prematurity: More Than Meets the ICROP?

Layla Ghergherehchi1, Sang Jin Kim1,2, J Peter Campbell1

  • 1Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.

Insights

Retinopathy of prematurity (ROP) diagnosis shows variability despite a standard definition for plus disease. More objective methods are needed for accurate diagnosis and consistent treatment of this leading cause of childhood blindness.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Medical Imaging

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of childhood blindness in premature infants.
  • Plus disease, characterized by specific retinal vascular changes, is crucial for identifying ROP requiring treatment.
  • Current diagnostic criteria for plus disease exhibit considerable variability in interpretation among experts.

Purpose of the Study:

  • To investigate the reasons behind diagnostic variability in retinopathy of prematurity plus disease.
  • To highlight the need for more precise definitions and objective diagnostic tools for ROP.

Main Methods:

  • Analysis of factors contributing to inter- and intra-expert agreement on plus disease diagnosis.
  • Review of proposed explanations for diagnostic inconsistencies, including vascular feature interpretation and image viewing parameters.

Main Results:

  • Significant variability exists in the diagnostic process and outcomes for plus disease, leading to inconsistent expert agreement.
  • Factors such as attention to undefined vascular features, field of view, digital image familiarity, and subjective cut-off points contribute to diagnostic discrepancies.
  • Geographical and chronological differences in expert diagnostic consistency have been reported.

Conclusions:

  • The current definition of plus disease in ROP, despite international acceptance, results in significant diagnostic variability.
  • There is a critical need for a more precise definition of plus disease and the development of objective diagnostic methods for ROP.
  • Improved diagnostic consistency is essential for effective clinical care, research, and education in managing ROP.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
565
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
580